• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学革命:干细胞治疗的最新进展与未来前景

Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.

作者信息

Hussen Bashdar M, Taheri Mohammad, Yashooa Raya Kh, Abdullah Gaylany H, Abdullah Snur R, Kheder Ramiar Kamal, Mustafa Suhad A

机构信息

Department of Biomedical Sciences, Cihan University-Erbil.

Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq.

出版信息

Int J Surg. 2024 Dec 1;110(12):8002-8024. doi: 10.1097/JS9.0000000000002109.

DOI:10.1097/JS9.0000000000002109
PMID:39497543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11634165/
Abstract

Stem-cell therapy is a revolutionary frontier in modern medicine, offering enormous capacity to transform the treatment landscape of numerous debilitating illnesses and injuries. This review examines the revolutionary frontier of treatments utilizing stem cells, highlighting the distinctive abilities of stem cells to undergo regeneration and specialized cell differentiation into a wide variety of phenotypes. This paper aims to guide researchers, physicians, and stakeholders through the intricate terrain of stem-cell therapy, examining the processes, applications, and challenges inherent in utilizing stem cells across diverse medical disciplines. The historical journey from foundational contributions in the late 19th and early 20th centuries to recent breakthroughs, including ESC isolation and iPSC discovery, has set the stage for monumental leaps in medical science. Stem cells' regenerative potential spans embryonic, adult, induced pluripotent, and perinatal stages, offering unprecedented therapeutic opportunities in cancer, neurodegenerative disorders, cardiovascular ailments, spinal cord injuries, diabetes, and tissue damage. However, difficulties, such as immunological rejection, tumorigenesis, and precise manipulation of stem-cell behavior, necessitate comprehensive exploration and innovative solutions. This manuscript summarizes recent biotechnological advancements, critical trial evaluations, and emerging technologies, providing a nuanced understanding of the triumphs, difficulties, and future trajectories in stem cell-based regenerative medicine. Future directions, including precision medicine integration, immune modulation strategies, advancements in gene-editing technologies, and bioengineering synergy, offer a roadmap in stem cell treatment. The focus on stem-cell therapy's potential highlights its significant influence on contemporary medicine and points to a future in which individualized regenerative therapies will alleviate various medical disorders.

摘要

干细胞疗法是现代医学中的一个革命性前沿领域,具有巨大潜力来改变众多使人衰弱的疾病和损伤的治疗格局。本综述探讨了利用干细胞进行治疗的革命性前沿领域,强调了干细胞进行再生以及分化为多种表型的特殊细胞的独特能力。本文旨在引导研究人员、医生和利益相关者穿越干细胞疗法的复杂领域,审视在不同医学学科中利用干细胞所固有的过程、应用和挑战。从19世纪末和20世纪初的基础性贡献到近期的突破,包括胚胎干细胞的分离和诱导多能干细胞的发现,这一历史进程为医学科学的巨大飞跃奠定了基础。干细胞的再生潜力涵盖胚胎、成人、诱导多能和围产期阶段,在癌症、神经退行性疾病、心血管疾病、脊髓损伤、糖尿病和组织损伤等方面提供了前所未有的治疗机会。然而,诸如免疫排斥、肿瘤发生以及对干细胞行为的精确操控等困难,需要进行全面探索并找到创新解决方案。本手稿总结了近期的生物技术进展、关键试验评估和新兴技术,对基于干细胞的再生医学的成就、困难和未来发展轨迹提供了细致入微的理解。未来的方向,包括精准医学整合、免疫调节策略、基因编辑技术的进步以及生物工程协同作用,为干细胞治疗提供了路线图。对干细胞疗法潜力的关注凸显了其对当代医学的重大影响,并指向一个个性化再生疗法将缓解各种医学病症的未来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/767a7fa104b7/js9-110-8002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/123acad35671/js9-110-8002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/642f2095ada7/js9-110-8002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/0c00efd51074/js9-110-8002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/1d919804cc28/js9-110-8002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/c1aec9c4489b/js9-110-8002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/767a7fa104b7/js9-110-8002-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/123acad35671/js9-110-8002-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/642f2095ada7/js9-110-8002-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/0c00efd51074/js9-110-8002-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/1d919804cc28/js9-110-8002-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/c1aec9c4489b/js9-110-8002-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9d7/11634165/767a7fa104b7/js9-110-8002-g006.jpg

相似文献

1
Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.医学革命:干细胞治疗的最新进展与未来前景
Int J Surg. 2024 Dec 1;110(12):8002-8024. doi: 10.1097/JS9.0000000000002109.
2
Unlocking the therapeutic potential: odyssey of induced pluripotent stem cells in precision cell therapies.释放治疗潜力:诱导多能干细胞在精准细胞治疗中的探索历程
Int J Surg. 2024 Oct 1;110(10):6432-6455. doi: 10.1097/JS9.0000000000001892.
3
Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working Group.扩大基于多能干细胞的疗法——考量因素、当前挑战及新兴技术:国际细胞治疗协会新兴再生医学工作组观点
Cytotherapy. 2025 Apr 7. doi: 10.1016/j.jcyt.2025.04.058.
4
Current advancements in nanotechnology for stem cells.用于干细胞的纳米技术的当前进展。
Int J Surg. 2024 Dec 1;110(12):7456-7476. doi: 10.1097/JS9.0000000000002082.
5
Innovative approaches in stem cell therapy: revolutionizing cancer treatment and advancing neurobiology - a comprehensive review.干细胞治疗的创新方法:革新癌症治疗与推动神经生物学发展——全面综述
Int J Surg. 2024 Dec 1;110(12):7528-7545. doi: 10.1097/JS9.0000000000002111.
6
Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.诱导多能干细胞技术作为一种潜在的脊髓损伤临床治疗方法的系统评价。
Cell Transplant. 2013;22(4):571-617. doi: 10.3727/096368912X655208. Epub 2012 Aug 27.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Advances in Regenerative Medicine, Cell Therapy, and 3D Bioprinting for Corneal, Oculoplastic, and Orbital Surgery.再生医学、细胞疗法及3D生物打印在角膜、眼整形和眼眶手术中的进展
Adv Exp Med Biol. 2025 Mar 26. doi: 10.1007/5584_2025_855.
9
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine.肌萎缩侧索硬化症治疗与管理的最新治疗进展:再生医学时代
Expert Rev Neurother. 2025 Jul;25(7):773-789. doi: 10.1080/14737175.2025.2508781. Epub 2025 May 21.
10
Global research dynamics in the induced pluripotent stem cell and diabetes: A bibliometric analysis of the past twenty years.诱导多能干细胞与糖尿病领域的全球研究动态:过去二十年的文献计量分析
Regen Ther. 2025 Jul 5;30:341-350. doi: 10.1016/j.reth.2025.06.015. eCollection 2025 Dec.

引用本文的文献

1
Categories, applications, and potential of stem cells in bone regeneration: an overview.干细胞在骨再生中的分类、应用及潜力:综述
Front Med (Lausanne). 2025 Aug 20;12:1606100. doi: 10.3389/fmed.2025.1606100. eCollection 2025.
2
Cardiovascular and Metabolic Disease: New Treatment and Future Directions-The 3rd Edition.心血管与代谢疾病:新疗法与未来方向——第三版
Biomedicines. 2025 Aug 6;13(8):1914. doi: 10.3390/biomedicines13081914.
3
Genetic Architecture of Ischemic Stroke: Insights from Genome-Wide Association Studies and Beyond.

本文引用的文献

1
The Role of the Notch Signaling Pathway in the Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells.Notch 信号通路在人脐带间充质干细胞分化中的作用。
Front Biosci (Landmark Ed). 2024 Feb 21;29(2):74. doi: 10.31083/j.fbl2902074.
2
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?间充质基质细胞(MSCs)作为炎症性疾病和传染性新冠病毒的治疗剂:活的还是死的间充质细胞?
Mol Biol Rep. 2024 Feb 10;51(1):295. doi: 10.1007/s11033-023-09174-x.
3
Next-generation therapeutics for rare genetic disorders.
缺血性中风的遗传结构:全基因组关联研究及其他方面的见解
J Cardiovasc Dev Dis. 2025 Jul 23;12(8):281. doi: 10.3390/jcdd12080281.
4
From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence.从实验台到病床边:通过临床前和临床证据转化间充质干细胞疗法。
Front Bioeng Biotechnol. 2025 Jul 30;13:1639439. doi: 10.3389/fbioe.2025.1639439. eCollection 2025.
5
Precision Neuro-Oncology in Glioblastoma: AI-Guided CRISPR Editing and Real-Time Multi-Omics for Genomic Brain Surgery.胶质母细胞瘤中的精准神经肿瘤学:用于基因组脑手术的人工智能引导的CRISPR编辑和实时多组学技术
Int J Mol Sci. 2025 Jul 30;26(15):7364. doi: 10.3390/ijms26157364.
6
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024.过去十年全球肾脏疾病干细胞治疗的热点与趋势:2015年至2024年的文献计量与可视化分析
Front Immunol. 2025 Jul 21;16:1619291. doi: 10.3389/fimmu.2025.1619291. eCollection 2025.
7
Epigenetic Modifications in the Retinal Pigment Epithelium of the Eye During RPE-Related Regeneration or Retinal Diseases in Vertebrates.脊椎动物视网膜色素上皮相关再生或视网膜疾病期间眼部视网膜色素上皮中的表观遗传修饰
Biomedicines. 2025 Jun 25;13(7):1552. doi: 10.3390/biomedicines13071552.
8
Regenerative potential of PRP-based scaffolds in chronic wound healing: Mechanisms, advances, and therapeutic insights.基于富血小板血浆的支架在慢性伤口愈合中的再生潜力:机制、进展及治疗见解。
Regen Ther. 2025 Jun 26;30:278-298. doi: 10.1016/j.reth.2025.06.008. eCollection 2025 Dec.
9
Pharmacological modulation of stem cells signaling pathway for therapeutic applications.用于治疗应用的干细胞信号通路的药理学调节。
Stem Cell Res Ther. 2025 Jul 1;16(1):327. doi: 10.1186/s13287-025-04438-8.
10
Smart coacervate microdroplets: biomimetic design, material innovations, and emerging applications in biomacromolecule delivery.智能凝聚微滴:仿生设计、材料创新及在生物大分子递送中的新兴应用
Bioact Mater. 2025 Jun 10;52:244-270. doi: 10.1016/j.bioactmat.2025.06.016. eCollection 2025 Oct.
用于罕见遗传疾病的下一代疗法。
Mutagenesis. 2024 Apr 24;39(3):157-171. doi: 10.1093/mutage/geae002.
4
Human Umbilical Cord Mesenchymal Stem Cells Improve Lung Function in Chronic Obstructive Pulmonary Disease Rat Model Through Regulating Lung Microbiota.人脐带间充质干细胞通过调节肺微生物群改善慢性阻塞性肺疾病大鼠模型的肺功能
Stem Cells. 2024 Apr 15;42(4):346-359. doi: 10.1093/stmcls/sxae007.
5
Advancements and mechanisms of stem cell-based therapies for spinal cord injury in animals.动物脊髓损伤干细胞疗法的进展与机制
Int J Surg. 2024 Oct 1;110(10):6182-6197. doi: 10.1097/JS9.0000000000001074.
6
Induced Pluripotent Stem Cell-Derived Cardiomyocytes Therapy for Ischemic Heart Disease in Animal Model: A Meta-Analysis.诱导多能干细胞衍生的心肌细胞治疗动物模型缺血性心脏病的Meta 分析。
Int J Mol Sci. 2024 Jan 12;25(2):987. doi: 10.3390/ijms25020987.
7
Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on β654-Thalassemia.基因编辑小鼠来源的造血干细胞对β654-地中海贫血的治疗效果。
Stem Cells. 2024 Mar 14;42(3):278-289. doi: 10.1093/stmcls/sxad096.
8
Development of a thick and functional human adipose-derived stem cell tissue sheet for myocardial infarction repair in rat hearts.用于修复大鼠心脏心肌梗死的厚且功能强大的人脂肪来源干细胞组织片的研制。
Stem Cell Res Ther. 2023 Dec 20;14(1):380. doi: 10.1186/s13287-023-03560-9.
9
Intravenous administration of human chorionic membrane mesenchymal stem cells promotes functional recovery in a rat traumatic brain injury model.静脉注射人绒毛膜间充质干细胞促进大鼠创伤性脑损伤模型的功能恢复。
Neuroreport. 2024 Feb 7;35(2):81-89. doi: 10.1097/WNR.0000000000001981. Epub 2023 Dec 12.
10
A new generation of mesenchymal stromal/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment.在狼疮微环境中,经免疫调节益生菌差异化训练的新一代间充质基质/干细胞。
Stem Cell Res Ther. 2023 Dec 10;14(1):358. doi: 10.1186/s13287-023-03578-z.